South & Central America Airway Management Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Infraglottic Devices (Endotracheal Tubes, Tracheostomy Tubes, and Others), Supraglottic Devices, Laryngoscopes, Resuscitators,

South & Central America Airway Management Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Infraglottic Devices (Endotracheal Tubes, Tracheostomy Tubes, and Others), Supraglottic Devices, Laryngoscopes, Resuscitators, and Others] and End User (Hospitals, Ambulatory Surgical Care Centers, and Others)

The airway management devices market in South & Central America is expected to grow from US$ 97.52 million in 2022 to US$ 141.70 million by 2028. It is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

Extending Research and Development Activities and Collaborations Among Market Players

Medical device research and development are considered highly capital-intensive and fraught with enormous risks. R&D is an essential step, after which the best ideas are converted into the best products. A thriving R&D ecosystem can become the perfect nurturing ground for developing competitive and top-of-the-line products, from conceiving an ideal product design to new product development, prototyping, validation, and testing. To produce innovative products, MedTech companies are investing a huge part of revenue in R&D. With a continued focus on developing and commercializing new, innovative products and solutions, the company aims to improve patient outcomes, help physicians and providers better manage chronic disease, and lower healthcare costs. Furthermore, there have been several strategic collaborations among market players to share resources such as research, manufacturing, design, and technology for developing new and innovative products in the market. The market players are mostly involved in joint ventures, partnerships, and mergers & acquisitions, which is likely to promote market growth. A few strategic initiatives taken by the market players are given below. Further, in May 2021, Teleflex entered into a definitive agreement to sell certain product lines within the global respiratory product portfolio to Medline Industries Inc. Similarly, In May 2021, Medline signed a definitive agreement to acquire select assets under the Hudson RCI brand of Teleflex’s Respiratory business. Thus, all the above-mentioned factors are expected to promote the growth of airway management devices market in the near future.

Market Overview

The South & Central America airway management devices market is segmented into Argentina, Brazil, and the Rest of South & Central America. The South & Central America airway management devices market is expected to grow at a CAGR of 6.4% during the forecast period. The market growth is attributed to the growing aging population, the flourishing demand for airway management devices, and the rising initiatives by major players operating in the medical device industry. Furthermore, the rising prevalence of respiratory diseases that demand airway management devices is one of the factors contributing to the market growth.

South & Central America Airway Management Devices Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Airway Management Devices Market Segmentation

The South & Central America airway management devices market is segmented into product, end user, and country.

Based on product, the market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment registered the largest market share in 2022.

Based on end user, the market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022.

Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Medline Industries, Inc.; Koninklijke Philips N.V.; and ARMSTRONG MEDICAL are among the leading companies operating in the airway management devices market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America waxy maize starch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America waxy maize starch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the waxy maize starch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution